eccogene glp 1 AstraZeneca licenses Eccogene's oral GLP-1 for $185M upfront AZD5004
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
AZD5004 New GLP 1 receptor agonists identified at Eccogene BioWorld Nonclinical and firstinhuman characterization of ECC5004 AZD5004, a novel oncedaily, oral smallmolecule GLP1 receptor agonist Haggag 2025 Diabetes, Obesity and Metabolism Wiley Online Library Oral GLP 1 Market to Rise at 35.05% CAGR till 2035
Store: matisco.be · Domain: matisco.be






.png?sfvrsn=1e7191c0_3)















